A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of Pittsburgh study published today in Science Translational Medicine.
Benuvia Operations, LLC, a global contract development and manufacturing organization, today announced the company has entered into a licensing agreement with Avernus Pharma, a leading provider and ...
Celltrion's asthma treatment Omlyclo, a biosimilar of Novartis's Xolair, has received Canadian approval for chronic urticaria, rhinosinusitis, and allergic asthma ...